Lv6184
2760 积分 2024-09-18 加入
Targeted and immunotherapy for the management of advanced urothelial carcinoma of the bladder
1个月前
已完结
Faculty Opinions recommendation of The health economics of bladder cancer: a comprehensive review of the published literature
1个月前
已关闭
Clinical model of lifetime cost of treating bladder cancer and associated complications
1个月前
已完结
Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA/SUO Guideline: 2024 Amendment
1个月前
已完结
Tumor-Microenvironment Characterization of the MB49 Non-Muscle-Invasive Bladder-Cancer Orthotopic Model towards New Therapeutic Strategies
1个月前
已完结
Imaging and Downstaging Bladder Cancer with the 177Lu-Labeled Bioorthogonal Nanoprobe
1个月前
已完结
Imaging and Downstaging Bladder Cancer with the 177Lu-Labeled Bioorthogonal Nanoprobe
2个月前
已完结
Preclinical and Clinical Feasibility Studies as the First Step Before Forthcoming Intravesical Instillation of [211At]At-anti-CA-IX Antibody (ATO-101™) Study in Patients with Non-Muscle-Invasive Bladder Cancer Unresponsive to Standard of Care
3个月前
已完结
The development of 177Lu-DOTA-CC-PSMA following a unified “Click Chemistry” protocol of synthesizing metal nuclide-conjugated radiopharmaceuticals
3个月前
已完结
Preclinical Efficacy of a PSMA-Targeted Actinium-225 Conjugate (225Ac-Macropa-Pelgifatamab): A Targeted Alpha Therapy for Prostate Cancer
3个月前
已完结
皖公网安备34019202002308
